TransEnterix (NYSE:TRXC) announced that it closed its previously announced public offering with gross proceeds totaling approximately $15 million.
Research Triangle Park, N.C.-based TransEnterix last week priced the offering of nearly 37.3 million shares of common stock at a public offering price of 35¢ per share, anticipating $13 million in proceeds, before deducting underwriter discounts and commissions and expenses payable by the company.
Upon closing the offering, TransEnterix confirmed that the $15 million in gross proceeds includes the full exercise of the underwriter’s over-allotment option to purchase additional shares.
In total, the surgical robotics company issued nearly 42.9 million shares of common stock at 35¢ per share and expects total net proceeds of about $13.7 million, which is earmarked for general corporate purposes, including working capital, according to a news release.
Ladenburg Thalmann & Co. acted as sole book-running manager in connection with the offering.